Pancreatic cancer genetic epidemiology consortium

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 4, 2006, Pages 704-710

  Petersen, Gloria M ^a   De Andrade, Mariza ^a   Goggins, Michael ^b   Hruban, Ralph H ^b   Bondy, Melissa ^c   Korczak, Jeannette F ^d   Gallinger, Steven ^e   Lynch, Henry T ^f   Syngal, Sapna ^g   Rabe, Kari G ^a   Seminara, Daniela ^h   Klein, Alison P ^b  

^a Mayo Clinic   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d WAYNE STATE UNIVERSITY   (United States)

^e MOUNT SINAI HOSPITAL   (Canada)

^f CREIGHTON UNIVERSITY   (United States)

^g DANA FARBER CANCER INSTITUTE   (United States)

^h NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; DEMOGRAPHY; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PEDIGREE ANALYSIS; PRIORITY JOURNAL; QUESTIONNAIRE;

AGE OF ONSET; COOPERATIVE BEHAVIOR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; PANCREATIC NEOPLASMS; SEER PROGRAM; UNITED STATES;

EID: 33646231772     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0734     Document Type: Article

References (51)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
2. Ries LAG, Eisner MP, Kosary CL, et al., editors. SEER Cancer Statistics Review, 1975-2002, National Cancer Institute. Bethesda, MD, based on November 2004 SEER data submission, posted to the SEER web site 2005 [cited 2006 Jan 12]. Available from: http://seer.cancer.gov/csr/1975_2002/.
3. Yeo TP, Hruban RH, Leach SD, et al. Pancreatic cancer. Curr Probl Cancer 2002;26:176-275.
4. Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. Lancet 2004;363:1049-57.
5. Ehrenthal D, Haeger L, Griffin T, Compton C. Familial pancreatic adenocarcinoma in three generations. A case report and a review of the literature. Cancer 1987;59:1661-4.
6. Ghadirian P, Simard A, Baillargeon J. Cancer of the pancreas in two brothers and one sister. Int J Pancreatol 1987;2:383-91.
7. Dat NM, Sontag SJ. Pancreatic carcinoma in brothers. Ann Intern Med 1982;97:282.
8. MacDermott RP, Kramer P. Adenocarcinoma of the pancreas in four siblings. Gastroenterology 1973;65:137-9.
9. Friedman JM, Fialkow PJ. Familial carcinoma of the pancreas. Clin Genet 1976;9:463-9.
10. Ghadirian P, Boyle P, Simard A, et al. Reported family aggregation of pancreatic cancer within a population-based case-control study in the Francophone community in Montreal, Canada. Int J Pancreatol 1991;10:183-96.
11. Fernandez E, La Vecchia C, D'Avanzo B, et al. Family history and the risk of liver, gallbladder, and pancreatic cancer. Cancer Epidemiol Biomarkers Prev 1994;3:209-12.
12. Falk RT, Pickle LW, Fontham ET, et al. Life-style risk factors for pancreatic cancer in Louisiana: a case-control study. Am J Epidemiol 1988;128:324-36.
13. Silverman DT, Schiffman M, Everhart J, et al. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer 1999;80:1830-7.
14. Schenk M, Schwartz AG, O'Neal E, et al. Familial risk of pancreatic cancer. J Natl Cancer Inst 2001;93:640-4.
15. McWilliams RR, Rabe KG, Olswold C, et al. Risk of malignancy in first-degree relatives of pancreatic cancer patients. Cancer 2005;104:388-94.
16. Amundadottir LT, Thorvaldsson S, Gudbjartsson DF, et al. Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family. PLoS Med 2004;1:e65.
17. Coughlin SS, Calle EE, Patel AV, Thun MJ. Predictors of pancreatic cancer mortality among a large cohort of United States adults. Cancer Causes Control 2000;11:915-23.
18. Klein AP, Brune KA, Petersen GM, et al. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res 2004;64:2634-8.
19. Hruban RH, Petersen GM, Ha PK, Kern SE. Genetics of pancreatic cancer. From genes to families. Surg Oncol Clin N Am 1998;7:1-23.
20. Lynch HT, Smyrk T, Kern SE, et al. Familial pancreatic cancer: a review. Semin Oncol 1996;23:251-75.
21. Lal G, Liu G, Schmocker B, et al. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations. Cancer Res 2000;60:409-16.
22. Murphy KM, Brune KA, Griffin C, et al. Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%. Cancer Res 2002;62:3789-93.
23. Hahn SA, Greenhalf B, Ellis I, et al. BRCA2 germline mutations in familial pancreatic carcinoma. J Natl Cancer Inst 2003;95:214-21.
24. Rogers CD, van der Heijden MS, Brune K, et al. The genetics of FANCC and FANCG in familial pancreatic cancer. Cancer Biol Ther 2004;3:167-9.
25. Rogers CD, Couch FJ, Brune K, et al. Genetics of the FANCA gene in familial pancreatic cancer. J Med Genet 2004;41:el26.
26. Eberle MA, Pfutzger R, Pogue-Geile KL, et al. A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32-34. Am J Hum Genet 2002;70:1044-8.
27. Klein AP, Beaty TH, Bailey-Wilson JE, et al. Evidence for a major gene influencing risk of pancreatic cancer. Genet Epidemiol 2002;23:133-49.
28. Rulyak SJ, Lowenfels AB, Maisonneuve P, Brentnall TA. Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds. Gastroenterology 2003;124:1292-9.
29. James TA, Sheldon DG, Rajput A, et al. Risk factors associated with earlier age of onset in familial pancreatic carcinoma. Cancer 2004;101:2722-6.
30. Bailey-Wilson JE, Amos CI, Pinney SM, et al. A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet 2004;75:460-74.
31. Center for Inherited Disease Research [homepage on the Internet]. Genotyping services [updated 2006 Jan 6; cited 2006 Jan 12]. Available from: http://www.cidr.jhmi.edu/index.html.
32. WHO. International classification of diseases for oncology. Imprint. Geneva: WHO; 1976.
33. National Cancer Institute [homepage on the Internet]. U S. National Institutes of Health. Certificates of confidentiality [updated 2005 Jan 1; cited 2006 Jan 12]. Available at: http://www.cancer.gov/clinicaltrials/conducting/certificates-of-confidentiality.
34. Weeks DE, Ott J, Lathrop GM, SLINK: a general simulation program for linkage analysis [abstract]. Am J Hum Genet 1990;47:A204.
35. Goggins M, Hruban RH, Kern SE. BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications. Am J Pathol 2000;156:1767-71.
36. Rosty C, Ueki T, Argani P, et al. Overexpression of S100A4 in pancreatic ductal adenocarcinomas associated with poor differentiation and DNA hypomethylation. Am J Pathol 2002;160:45-50.
37. National Cancer Institute [homepage on the Internet]. Surveillance Epidemiology and End Results (SEER) Program. SEER*Stat Database: Incidence - SEER 13 Regs Public-Use, Nov 2004 Sub (1973-2002 varying), National Cancer Institute DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2005, based on the November 2004 submission [cited 2006 Jan 12]. Available from: http://www.seer.cancer.gov.
38. National Cancer Institute [homepage on the Internet]. Surveillance Research Program, National Cancer Institute SEER*Stat software version 6.1.4 [cited 2006 Jan 12]. Available from: http://www.seer.cancer.gov/seerstat.
39. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
40. King MC, Marks JH, Mandell JB. New York Breast Cancer Study Group. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003;302:643-6.
41. Voskuil DW, Vasen HF, Kampman E, van't Veer P. Colorectal cancer risk in HNPCC families: development during lifetime and in successive generations. National Collaborative Group on HNPCC. Int J Cancer 1997;72:205-9.
42. Bermejo J, Hemminki K. Risk of cancer at sites other than the breast in Swedish families eligible for BRCA1 or BRCA2 mutation testing. Ann Oncol 2004;15:1834-41.
43. Lynch HT, Fusaro RM. Pancreatic cancer and the familial atypical multiple mole melanoma (FAMMM) syndrome. Pancreas 1991;6:127-31.
44. INK4 mutations. N Engl J Med 1995;333:970-4.
45. Giardiello FM, Brensinger JD, Tersmette AC, et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 2000;119:1447-53.
46. van der Heijden MS, Yeo CJ, Hruban RH, Kern SE. Fanconi anemia gene mutations in young-onset pancreatic cancer. Cancer Res 2003;63:2585-8.
47. Couch FJ, Johnson MR, Rabe K, et al. Germ line Fanconi anemia complementation group C mutations and pancreatic cancer. Cancer Res 2005;65:383-6.
48. Whitcomb DC, Gorry MC, Preston RA, et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996;14:141-5.
49. Whitcomb DC, Preston RA, Aston CE, et al. A gene for hereditary pancreatitis maps to chromosome 7q35. Gastroenterology 1996;110:1975-80.
50. Lynch HT, Voorhees GJ, Lanspa SJ, et al. Pancreatic carcinoma and hereditary nonpolyposis colorectal cancer: a family study. Br J Cancer 1985;52:271-3.
51. McWilliams R, Highsmith WE, Rabe KG, et al. Cystic fibrosis transmembrane regulator gene carrier status is a risk factor for young onset pancreatic adenocarcinoma. Gut 2005;54:1661-2.